Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX)
CAPS Rating:
A biopharmaceutical company building an oncology business by developing and commercializing innovative therapies that target the molecular mechanisms implicated in cancer.
RSS Headlines
Fool UK
Recs
my be a bore in the short term, but long term it will be a winner